SIU-B2B Meeting Eng

10:00-14:30 Joint Meeting SIU / HUA: Bench to Bedside (B2B) -Prostate Cancer

Chairmen: Iraklis Poulias , Athanasios Papatsoris

10:00-10:10 Introduction & Welcome by the Chairmen of B2B meeting

Iraklis Poulias President of H.U.A.

Athanasios Papatsoris, General Secretary of H.U.A.

10:10-12:30 Localized and hormone sensitive PCa

Moderators: Jean de la Rosette, Ioannis Varkarakis

10:10-10:30 Clinical and Molecular variability of Prostate Cancer

Dr Selcuk Guven, Turkey

10:30-10:50 The role of lymphadenectomy in Prostate Cancer & novel achievement in Robotic Prostatectomy

Dr Paolo Gontero, Italy

10:50-11:10 Novel achievements of robotic radical prostatectomy

Markos Karavitakis , Greece

11:10-11:30 Management of biochemical and loco-regional recurrence

Ioannis Varkarakis, Greece

11:30-11:50 The role of LHRH antagonists

Dr Selcuk Guven, Turkey

11:50-12:10 Novel antiandrogens in PCa M0

Dr Paolo Gontero, Italy

12:10-12:30 Chemo-hormone treatment in hormone sensitive disease

Georgios Moutzouris, Greece

12:30-13:30 Break & Light Lunch  

Castration Resistant PCa

Moderators:  Alkiviadis Grigorakis, Ioannis Gkialas


 Diagnosis and management of CRPC M0

Georgios Papadopoulos, Greece


Sequencing of medications in CRPC M+

Theodoros Kalogeropoulos, Greece


Non urological considerations in CRPC

Dr Paolo Gontero, Italy